65 related articles for article (PubMed ID: 27025323)
1. Fine-tuning risk assessment with antiepileptic drug use in pregnancy.
Mawer G; Bromley R; Baker GA; Meador KJ; Clayton-Smith J
Neurology; 2015 Oct; 85(15):1354. PubMed ID: 26459942
[No Abstract] [Full Text] [Related]
2. Type of Prenatal Antiseizure Drug Matters for Children's Autism Risk.
Harris E
JAMA; 2024 May; 331(18):1525. PubMed ID: 38639978
[No Abstract] [Full Text] [Related]
3. Female paediatric patients with epilepsy who continue to receive valproate in the UK.
Lang L; Dunbar-Creasey N; Kneen R; Neely L; Hawcutt DB
Arch Dis Child; 2024 Jan; 109(2):174-175. PubMed ID: 38041674
[No Abstract] [Full Text] [Related]
4. Valproate: Weighing the Unique Risks.
Johnson EL
Neurology; 2024 May; 102(9):e209325. PubMed ID: 38569129
[No Abstract] [Full Text] [Related]
5. The prescription of valproate: risk of harm.
Rugg-Gunn F; Hunt D
Lancet Neurol; 2024 Jun; 23(6):557-558. PubMed ID: 38760090
[No Abstract] [Full Text] [Related]
6. The prescription of valproate: risk of harm.
Cave A
Lancet Neurol; 2024 Jun; 23(6):557. PubMed ID: 38760089
[No Abstract] [Full Text] [Related]
7. Adverse Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medications: An Ever-Expanding Story.
Honybun E; Perucca P
Neurology; 2024 Jun; 102(12):e209553. PubMed ID: 38810176
[No Abstract] [Full Text] [Related]
8. The Valproic Acid Dilemma: Safe Alternatives For Pregnant Women And Women Of Childbearing Age With Epilepsy.
Abid M; ; Basit A
J Pak Med Assoc; 2023 Nov; 73(11):2302. PubMed ID: 38013559
[No Abstract] [Full Text] [Related]
9. Risks of Fetal Exposure to Topiramate.
Meador KJ
N Engl J Med; 2024 Mar; 390(12):1141-1142. PubMed ID: 38507757
[No Abstract] [Full Text] [Related]
10. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.
Petersen I; McCrea RL; Sammon CJ; Osborn DP; Evans SJ; Cowen PJ; Freemantle N; Nazareth I
Health Technol Assess; 2016 Mar; 20(23):1-176. PubMed ID: 27029490
[TBL] [Abstract][Full Text] [Related]
11. Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate.
Bromley RL; Calderbank R; Cheyne CP; Rooney C; Trayner P; Clayton-Smith J; García-Fiñana M; Irwin B; Morrow JI; Shallcross R; Baker GA;
Neurology; 2016 Nov; 87(18):1943-1953. PubMed ID: 27581218
[TBL] [Abstract][Full Text] [Related]
12. Adverse Effects in the Pharmacologic Management of Bipolar Disorder During Pregnancy.
Hogan CS; Freeman MP
Psychiatr Clin North Am; 2016 Sep; 39(3):465-75. PubMed ID: 27514299
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Epilepsia; 2016 Aug; 57(8):e173-7. PubMed ID: 27319360
[TBL] [Abstract][Full Text] [Related]
15. Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study.
Brodie MJ; Chung S; Wade A; Quelen C; Guiraud-Diawara A; François C; Verpillat P; Shen V; Isojarvi J
Epilepsy Res; 2016 Jul; 123():68-74. PubMed ID: 27135706
[TBL] [Abstract][Full Text] [Related]
16. Status epilepticus associated with pregnancy: A cohort study.
Lu YT; Hsu CW; Tsai WC; Cheng MY; Shih FY; Fu TY; Chuang YC; Tsai MH
Epilepsy Behav; 2016 Jun; 59():92-7. PubMed ID: 27116537
[TBL] [Abstract][Full Text] [Related]
17. Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa.
Mehta U; Smith M; Kalk E; Hayes H; Swart A; Tucker L; Coetzee R; Boulle A; Blockman M
Drug Saf; 2021 Jan; 44(1):41-51. PubMed ID: 32844313
[TBL] [Abstract][Full Text] [Related]
18. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
[TBL] [Abstract][Full Text] [Related]
19. France steps up warning measures for valproate drugs.
Casassus B
Lancet; 2016 Mar; 387(10024):1148. PubMed ID: 27025323
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
